Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Liabilities and Shareholders Equity (2016 - 2025)

Pediatrix Medical (MD) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 4.37% to $2.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 billion, a 1.77% increase, with the full-year FY2025 number at $2.2 billion, up 4.37% from a year prior.
  • Liabilities and Shareholders Equity was $2.2 billion for Q4 2025 at Pediatrix Medical, up from $2.2 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q4 2021 to a low of $2.0 billion in Q1 2025.
  • A 5-year average of $2.3 billion and a median of $2.3 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 42.5% in 2021, then rose 5.9% in 2025.
  • Pediatrix Medical's Liabilities and Shareholders Equity stood at $2.7 billion in 2021, then dropped by 13.76% to $2.3 billion in 2022, then fell by 5.45% to $2.2 billion in 2023, then dropped by 3.02% to $2.2 billion in 2024, then increased by 4.37% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MD's Liabilities and Shareholders Equity are $2.2 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.1 billion (Q2 2025).